全文获取类型
收费全文 | 27191篇 |
免费 | 1887篇 |
国内免费 | 39篇 |
专业分类
耳鼻咽喉 | 282篇 |
儿科学 | 967篇 |
妇产科学 | 706篇 |
基础医学 | 3390篇 |
口腔科学 | 249篇 |
临床医学 | 4725篇 |
内科学 | 4553篇 |
皮肤病学 | 395篇 |
神经病学 | 2386篇 |
特种医学 | 632篇 |
外科学 | 2788篇 |
综合类 | 350篇 |
现状与发展 | 1篇 |
一般理论 | 37篇 |
预防医学 | 3479篇 |
眼科学 | 356篇 |
药学 | 1899篇 |
2篇 | |
中国医学 | 39篇 |
肿瘤学 | 1881篇 |
出版年
2023年 | 147篇 |
2022年 | 184篇 |
2021年 | 535篇 |
2020年 | 355篇 |
2019年 | 535篇 |
2018年 | 635篇 |
2017年 | 533篇 |
2016年 | 531篇 |
2015年 | 613篇 |
2014年 | 833篇 |
2013年 | 1221篇 |
2012年 | 1857篇 |
2011年 | 1870篇 |
2010年 | 1075篇 |
2009年 | 971篇 |
2008年 | 1742篇 |
2007年 | 1888篇 |
2006年 | 1795篇 |
2005年 | 1685篇 |
2004年 | 1658篇 |
2003年 | 1520篇 |
2002年 | 1428篇 |
2001年 | 404篇 |
2000年 | 321篇 |
1999年 | 338篇 |
1998年 | 321篇 |
1997年 | 250篇 |
1996年 | 256篇 |
1995年 | 244篇 |
1994年 | 208篇 |
1993年 | 165篇 |
1992年 | 245篇 |
1991年 | 222篇 |
1990年 | 203篇 |
1989年 | 161篇 |
1988年 | 182篇 |
1987年 | 166篇 |
1986年 | 148篇 |
1985年 | 168篇 |
1984年 | 154篇 |
1983年 | 115篇 |
1982年 | 112篇 |
1981年 | 121篇 |
1980年 | 106篇 |
1979年 | 102篇 |
1978年 | 82篇 |
1977年 | 70篇 |
1976年 | 47篇 |
1974年 | 64篇 |
1973年 | 50篇 |
排序方式: 共有10000条查询结果,搜索用时 815 毫秒
91.
92.
Devang N Patel Francis D Pagani Todd M Koelling David B Dyke Ragavendra R Baliga Robert J Cody Kathleen D Lake Keith D Aaronson 《The Journal of heart and lung transplantation》2002,21(2):204-210
BACKGROUND: Pravastatin and simvastatin prolong survival and reduce transplant-related coronary vasculopathy, although low-density lipoprotein (LDL) lowering with these agents is only modest. The objective of this study was to assess the safety of moderate dose atorvastatin and its efficacy when prior treatment with another statin had failed to lower LDL to < 100 mg/dl. METHODS: Data from 185 patients were retrospectively evaluated for adverse events, duration of exposure (person-days), and the mean atorvastatin dose exposure. Changes in lipid parameters, and prednisone and cyclosporine doses were determined. RESULTS: Safety: 48 patients received atorvastatin for 24,240 person-days at a mean dose exposure of 21 +/- 10 mg. Rhabdomyolysis, myositis, myalgias, and hepatotoxicity occurred in 0, 2, 2, and 0 patients, respectively. All events occurred at the 10-mg dose, within the first 3 months, and were rapidly reversible with atorvastatin discontinuation. Efficacy: Thirty-four patients evaluable for efficacy analyses had a pre-atorvastatin LDL of 145 +/- 38 mg/dl on the following statins: pravastatin (n = 30, 40 +/- 0mg), fluvastatin (n = 3, 33 +/- 12 mg), simvastatin (n = 1, 40 mg). After atorvastatin (21 +/- 9 mg/day) for 133 +/- 67 days, LDL was reduced to 97 +/- 24 mg/dl (relative reduction 31 +/- 20%, p < 0.0001). At the end of the observation period (418 +/- 229 days, atorvastatin final dose 24 +/- 14 mg/day), LDL was further decreased to 88 +/- 23 mg (relative reduction 37 +/- 17%, p < 0.0001). CONCLUSION: Atorvastatin, when used at moderate doses and with close biochemical and clinical monitoring, appears to be safe and is effective in aggressively lowering LDL in heart transplant recipients when treatment with other statins has failed to achieve LDL goals. 相似文献
93.
Reinherz Helen Gordon Alan L. Morris Kathleen M. Anastas Jeane W. 《The journal of primary prevention》1983,4(2):73-95
Journal of Prevention - The major issues involved in the design and implementation of effective school screening programs are addressed, using data from a longitudinal study following over 500... 相似文献
94.
Little attention has been directed toward inappropriate social and sexual approaches by patients with dementia diagnoses and
organic disorders of the brain. A female student who approached patients who had dementia and organic brain disorders was
frequently approached and touched in a sexual manner that was distressing to her and led her to believe that she was behaving
in a manner that elicited these responses. It is recommended that students and volunteers be prepared for experience in settings
with patients with these diagnoses through individual or group discussion, training and role playing as a way of enhancing
their experiences and avoiding unnecessary feelings of guilt and embarrassment. 相似文献
95.
96.
Transconjunctival surgery provides excellent exposure of the inferior orbit, leaves no visible scar, and poses less risk of the complications typically associated with transcutaneous techniques. The transconjunctival approach can be combined with lateral canthal techniques to increase exposure and surgical options. We review applications of the transconjunctival approach in blepharoplasty, the repair of orbital floor fractures, socket reconstruction, inferior orbital tumor excision, and orbital decompression. 相似文献
97.
Optic nerve pathology was studied in C57BL/6J wabbler-lethal (wl/wl) and control (+/+) mice at postnatal age of 4 weeks (P28). Qualitative light and ultrastructural pathology in wl/wl animals conformed to the criteria of primary axonal (Wallerian) degeneration. Most optic nerve axons in mutant animals appeared normal, as did oligodendroglia, the degree of myelination, the integrity and maturity of vascular elements, astroglia, and most myelin. Still, degenerating axons surrounded by somewhat normal myelin and axons with thickened myelin sheaths were prevalent in wl/wl mice. Dysmyelination or hypomyelination was not evident. At P28, pathology appeared more prominent in large diameter fibers. In the optic nerve of wl/wl mice, axonal degeneration preceded myelin disruption, adding this nerve to other previously reported systems undergoing Wallerian degeneration in this mutant. 相似文献
98.
Products of the Frizzled family of tissue polarity genes have been identified as putative receptors for the Wnt family of signaling molecules. Wnt-signaling is implicated in the regulation of limb mesenchymal chondrogenesis, and our recent study indicates that N-cadherin and related activities are functionally involved in Wnt-7a-mediated inhibition of chondrogenesis. By using an in vitro high-density micromass culture system of chick limb mesenchymal cells, we have analyzed the spatiotemporal expression patterns and the effects on chondrogenesis of RCAS retroviral-mediated misexpression of Chfz-1 and Chfz-7, two Frizzled genes implicated in chondrogenic regulation. Chfz-1 expression was localized at areas surrounding the cartilaginous nodules at all time points examined, whereas Chfz-7 expression was limited to cellular aggregates during initial mesenchymal condensation, and subsequently was down-regulated from the centers toward the periphery of cartilage nodules at the time of chondrogenic differentiation, resembling the pattern of N-cadherin expression. Chondrogenesis in vitro was inhibited and limited to a smaller area of the culture upon misexpression of Chfz-7, but not affected by Chfz-1 misexpression. Analyses of cellular condensation and chondrogenic differentiation showed that the inhibitory action of Chfz-7 is unlikely to be at the chondrogenic differentiation step, but instead affects the earlier precartilage aggregate formation event. At 24 hr, expression of N-cadherin, a key component of the cellular condensation phase of chondrogenesis, was delayed/suppressed in Chfz-7 misexpressing cultures, and was limited to a significantly smaller cellular condensation area within the entire culture at 48 hr, when compared with control cultures. Chfz-1 misexpressing cultures appeared similar to control cultures at all time points. However, neither Chfz-1 nor Chfz-7 misexpression affected mesenchymal cell proliferation in vitro. These results suggest that Chfz-7 is active in regulating N-cadherin expression during the process of limb mesenchymal chondrogenesis and that Chfz-1 and Chfz-7 are involved in different Wnt-signaling pathways. 相似文献
99.
Dennis A. Revicki Harris Allen Kathleen Bungay Gordon H. Williams Milton C. Weinstein 《Journal of clinical epidemiology》1994,47(12):1333-1342
We examined the discriminant ability and responsiveness of the General Well-Being Adjustment Scale in patients enrolled in a randomized clinical trial of antihypertensive therapy. We also tried to translate the effects of physical symptoms on general well-being. This secondary analysis used demographic, clinical, physical symptom, and general well-being data for 545 white, male hypertensive patients. General well-being was measured by the General Well-Being Adjustment Scale (GWB) collected on 2 occasions over 8 weeks of treatment. Patients with any one of 14 physical symptoms or problems, compared to those without symptoms, had lower GWB scores (p < 0.003 to p < 0.0001). Decreases of 2.83–8.76 points in GWB scores were observed in patients developing physical symptoms over the 8 week study period (p < 0.05 to p < 0.0001). These effects were demonstrated in patients developing cold sensitivity, sexual problems, chest pain, shortness of breath, loss of taste, nausea, hot or cold spells, numbness and tingling, dry mouth, blurred vision, and dizziness. We conclude that the GWB is responsive to clinically meaningful changes in symptoms and may provide a more complete evaluation of the effects of medical treatment. The GWB is a valid and responsive measure of health status outcomes in the evaluation of antihypertensive treatment. 相似文献
100.
M. J. Ray P. A. Carroll S. J. E. Just G. A. T. Hawson J. H. N. Belt 《Journal of clinical monitoring and computing》1994,10(2):97-100
Objective. The Ciba Corning 512 coagulation monitor (CC512) can be used to monitor heparin therapy by performing an activated
partial thromboplastin time (APTT) at the patient’s bedside. This study was designed to compare the CC512 results to results
using the laboratory system. The relative sensitivities of both systems to the effect of oral anticoagulant therapy also was
investigated.Methods. Activated partial thromboplastin times were performed with both the CC512 and laboratory system on 74 specimens from patients
receiving IV heparin therapy, and on 14 specimens from patients on warfarin only. Heparin assays were performed on 43 of the
specimens from the heparinized patients.Results. When a patient was receiving heparin only, the APTT results of the CC512 proved to be similar to existing laboratory methods.
The CC512 APTT results of patients on warfarin only were markedly prolonged, whereas the laboratory APTTs were only slightly
affected.Conclusion. The CC512 results were comparable to the laboratory system. However, the CC512 APTT was more sensitive to the effect of
warfarin than the laboratory APTT system used in this study. CC512 APTT results on a patient receiving both oral and intravenous
anticoagulation could be misleading.
The authors wish to thank D.M. O’Brien and the nursing staff of the Coronary Care Unit for providing CC512 data and laboratory
specimens, and I. Smith for the preparation of graphics. We also wish to thank Australian Diagnostics Corporation, which provided
consumables. 相似文献